Overview

Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the bioavailability and pharmacokinetics of the 0.5 mg, 1 mg and 2.5 mg treprostinil diethanolamine tablet strengths in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
United Therapeutics
Treatments:
Treprostinil